Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Aiach

Showing results (151-160 of 236) with videos related to

Pageof 24
Sort By:
The Journal of Laboratory and Clinical Medicine|April 1, 1995
Mechanism of protein C deficiency in a patient with arginine 358 alpha 1-antitrypsin (Pittsburgh mutation): role in the maintenance of hemostatic balanceJ Emmerich, M Alhenc-Gelas, S Gandrille, et al.
Comptes Rendus Des Seances De L'Academie Des Sciences. Serie III, Sciences De La Vie|December 20, 1982
[Effect of a low molecular weight heparin derivative on the release of lipolytic activity in the blood]F Millot, J Etienne, M Aiach, et al.
Thrombosis Research|March 1, 1988
Heparin cofactor II in patients with deep venous thrombosis under heparin and oral anticoagulant therapyP Toulon, J F Vitoux, L Capron, et al.
Thrombosis and Haemostasis|February 19, 1990
A plasma clot lysis assay based on the release of fibrin degradation products: application to the diagnosis of hypofibrinolytic statesP Gaussem, S Gandrille, P Molho-Sabatier, et al.
Vascular Surgery|November 1, 1977
Intermittent treatment with streptokinase in arterial disease of the limbsJ N Fiessinger, M Aiach, G Brunet, et al.
Thrombosis Research|November 1, 1994
A phenylalanine 402 to leucine mutation is responsible for a stable inactive conformation of antithrombinJ Emmerich, G Chadeuf, M J Coetzee, et al.
European Journal of Clinical Investigation|June 1, 1991
Involvement of heparin cofactor II in chymotrypsin neutralization and in the pancreatic proteinase-antiproteinase interaction during acute pancreatitis in manP Toulon, G Chadeuf, J L Bouillot, et al.
British Journal of Haematology|January 31, 1998
Interdonor variability of platelet response to thrombin receptor activation: influence of PlA2 polymorphismD Lasne, M Krenn, V Pingault, et al.
Thrombosis and Haemostasis|March 1, 1996
Five novel mutations of the protein S active gene (PROS 1) in 8 Norman familiesJ Duchemin, J Y Borg, D Borgel, et al.
JAMA|February 26, 1988
Long-term treatment of acute deep venous thrombosis with low-molecular-weight heparin derivativeJ F Vitoux, J N Fiessinger, M Roncato, et al.
Pageof 24

Showing results (151-160 of 236) with videos related to

Sort By:
Pageof 24
The Journal of Laboratory and Clinical Medicine|April 1, 1995
Mechanism of protein C deficiency in a patient with arginine 358 alpha 1-antitrypsin (Pittsburgh mutation): role in the maintenance of hemostatic balanceJ Emmerich, M Alhenc-Gelas, S Gandrille, et al.
Comptes Rendus Des Seances De L'Academie Des Sciences. Serie III, Sciences De La Vie|December 20, 1982
[Effect of a low molecular weight heparin derivative on the release of lipolytic activity in the blood]F Millot, J Etienne, M Aiach, et al.
Thrombosis Research|March 1, 1988
Heparin cofactor II in patients with deep venous thrombosis under heparin and oral anticoagulant therapyP Toulon, J F Vitoux, L Capron, et al.
Thrombosis and Haemostasis|February 19, 1990
A plasma clot lysis assay based on the release of fibrin degradation products: application to the diagnosis of hypofibrinolytic statesP Gaussem, S Gandrille, P Molho-Sabatier, et al.
Vascular Surgery|November 1, 1977
Intermittent treatment with streptokinase in arterial disease of the limbsJ N Fiessinger, M Aiach, G Brunet, et al.
Thrombosis Research|November 1, 1994
A phenylalanine 402 to leucine mutation is responsible for a stable inactive conformation of antithrombinJ Emmerich, G Chadeuf, M J Coetzee, et al.
European Journal of Clinical Investigation|June 1, 1991
Involvement of heparin cofactor II in chymotrypsin neutralization and in the pancreatic proteinase-antiproteinase interaction during acute pancreatitis in manP Toulon, G Chadeuf, J L Bouillot, et al.
British Journal of Haematology|January 31, 1998
Interdonor variability of platelet response to thrombin receptor activation: influence of PlA2 polymorphismD Lasne, M Krenn, V Pingault, et al.
Thrombosis and Haemostasis|March 1, 1996
Five novel mutations of the protein S active gene (PROS 1) in 8 Norman familiesJ Duchemin, J Y Borg, D Borgel, et al.
JAMA|February 26, 1988
Long-term treatment of acute deep venous thrombosis with low-molecular-weight heparin derivativeJ F Vitoux, J N Fiessinger, M Roncato, et al.
Pageof 24